Propiedad y actividad de insiders de BioCryst Pharmaceuticals, Inc. (BCRX): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $8.43 |
| Capitalización | $2.1B |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $22.1M | $50.3M | $26.7M | $114.2M | $272.1M | $504.4M | $304.8M | $110.6M | $104.9M | $89.7M |
| Inversiones a Corto | $32.5M | $64.1M | $77.7M | $22.1M | $28.2M | $3.2M | $119.5M | $278.3M | $216.1M | $185.0M |
| Cuentas por Cobrar | $8.8M | $6.1M | $4.3M | $22.1M | $8.6M | $29.4M | $50.6M | $57.0M | $79.1M | $106.8M |
| Inventario | $500000 | -$37.8M | $1.6M | 0 | $7.0M | $15.8M | $27.5M | $28.7M | $8.1M | $5.4M |
| Activos Corrientes | $67.0M | $125.4M | $114.4M | $164.3M | $323.8M | $566.1M | $516.5M | $496.0M | $422.0M | $404.3M |
| Inmovilizado Material | $9.9M | $9.5M | $9.1M | $7.3M | $7.1M | $15.2M | $8.6M | $20.9M | $19.8M | $19.0M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $89.8M | $178.3M | $146.8M | $175.3M | $334.7M | $588.2M | $550.0M | $517.0M | $490.4M | $514.2M |
| Cuentas por Pagar | $4.3M | $6.3M | $7.8M | $14.0M | $18.7M | $27.8M | $14.4M | $20.9M | $11.6M | $15.8M |
| Deuda a Corto | $28.2M | $35.1M | $33.7M | $38.6M | $30.0M | 0 | 0 | 0 | $35.4M | 0 |
| Pasivos Corrientes | $54.4M | $74.8M | $69.5M | $92.3M | $105.7M | $103.7M | $105.5M | $150.0M | $160.4M | $196.1M |
| Deuda a Largo | $22.8M | $16.8M | $25.4M | $41.3M | $244.5M | $585.5M | $733.3M | $811.3M | $795.9M | $427.2M |
| Pasivos Totales | $88.3M | $94.5M | $97.6M | $137.0M | $354.0M | $695.1M | $844.6M | $972.5M | $966.4M | $633.3M |
| Reservas | -$566.1M | -$631.8M | -$732.0M | -$840.6M | -$1.02B | -$1.21B | -$1.45B | -$1.68B | -$1.77B | -$1.51B |
| Patrimonio Neto | -$566.1M | -$631.8M | -$732.0M | $38.3M | -$19.3M | -$107.0M | -$294.6M | -$455.5M | -$475.9M | -$119.2M |
| Deuda Total | $53.7M | $54.7M | $61.8M | $84.7M | $279.5M | $593.2M | $741.5M | $825.1M | $841.4M | $438.9M |
| Deuda Neta | -$9.9M | -$101.0M | -$65.0M | -$51.6M | -$20.9M | $85.6M | $317.1M | $436.2M | $520.4M | $164.1M |
| Capital Circulante | $12.6M | $50.6M | $44.9M | $72.0M | $218.1M | $462.4M | $411.0M | $346.0M | $261.6M | $208.3M |
Salud financiera
| Deuda / Patrimonio | -0.90 |
| Ratio corriente | 2.32 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.83 |
Rentabilidad
| Rentabilidad sobre capital | 101.55% |
| Rentabilidad sobre capital invertido | -88.96% |
| Rentabilidad sobre activos | -68.96% |
| Margen bruto | 23.52% |
| Margen operativo | -33.29% |
| Margen neto | -40.90% |
Empresas relacionadas: ARDX · MAZE · NTLA · PHVS · STOK · SYRE · TRVI
Explorar sector: Healthcare · Biotechnology
Más secciones de BCRX: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones